Pharmaceutical Companies News


'Pharmaceutical Companies' - 93 News Result(s)

  • Microsoft Gets Support In Gag Order Lawsuit From US Companies

    Microsoft Gets Support In Gag Order Lawsuit From US Companies

    Technology, media, pharmaceutical and other companies, along with major corporate lobbying groups, filed legal briefs in support of a Microsoft Corp lawsuit that aims to strike down a law preventing companies from telling customers the government is seeking their data.

  • Microsoft Gets Support In Gag Order Lawsuit From US Companies

    Microsoft Gets Support In Gag Order Lawsuit From US Companies

    Technology, media, pharmaceutical and other companies, along with major corporate lobbying groups, filed legal briefs on Friday in support of a Microsoft Corp lawsuit that aims to strike down a law preventing companies from telling customers the government is seeking their data.

  • US Regulator's Scrutiny On Indian Drug Makers To Remain Intense: Crisil

    US Regulator's Scrutiny On Indian Drug Makers To Remain Intense: Crisil

    Regulatory scrutiny of the US Food and Drug Administration (FDA) for domestic pharmaceutical facilities is expected to remain intense over the medium term, rating agency Crisil said on Wednesday.

  • Pharma Firms Look At Acquisition Of Niche Product Portfolios: ICICI Securities

    Pharma Firms Look At Acquisition Of Niche Product Portfolios: ICICI Securities

    Cash-rich large pharmaceutical firms in India are now looking at acquisition of niche product portfolios in regulated markets, a report said on Tuesday.

  • Pharma, Financials, Auto Stocks Give Consistent Returns In 20 Years: Centrum

    Pharma, Financials, Auto Stocks Give Consistent Returns In 20 Years: Centrum

    Pharmaceuticals, financials, consumer, auto and auto ancillary companies have consistently given high equity returns to the investors while sharp out performance has been observed in shares of small and mid-size businesses, during the last 20 years, says a report.

  • Sun Pharma, Almirall Enter Pact For Psoriasis Novel Biologic

    Sun Pharma, Almirall Enter Pact For Psoriasis Novel Biologic

    Drug major Sun Pharmaceutical and Spanish firm Almirall have entered into a licensing pact for development and commercialisation of tildrakizumab used for treatment of psoriasis in Europe.

  • Higher FDI Limit In Brownfield Pharma To Attract Latest Tech

    Higher FDI Limit In Brownfield Pharma To Attract Latest Tech

    The government said it has raised FDI limit in existing pharmaceutical companies to attract required capital, international best practices and latest technologies in the sector.

  • No Permission Given To Hike Drug Prices Beyond Limits: Minister

    No Permission Given To Hike Drug Prices Beyond Limits: Minister

    The government has not given a nod to any pharma firm to increase prices of drugs beyond permissible limits, Parliament was informed on Tuesday.

  • Pharma Stocks Outperform; Lupin, Sun Pharma Rise 2%

    Pharma Stocks Outperform; Lupin, Sun Pharma Rise 2%

    Shares of pharmaceutical companies such as Lupin, Sun Pharmaceuticals, Dr Reddy's Laboratories and Aurobindo Pharma outperformed today in an otherwise subdued market.

  • Pharma Companies Hail New FDI Norms

    Pharma Companies Hail New FDI Norms

    The Organisation of Pharmaceutical Producers of India (OPPI) on Monday welcomed the Centre's decision to allow up to 74 per cent Foreign Direct Investment (FDI) in pharmaceutical sector under the automatic route.

  • Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies

    Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies

    Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.

  • This Country Owes Indian Firms A Lot Of Money. It May Pay With Oil.

    This Country Owes Indian Firms A Lot Of Money. It May Pay With Oil.

    Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies.

  • Pharma Exports Growth Heading For Sharp Decline: Crisil

    Pharma Exports Growth Heading For Sharp Decline: Crisil

    The annual sales growth of generic drugs in the US, the largest generics market, is seen slowing to 8-9 per cent over the next five years, and decelerate even more after that.

  • Pharma Exports Growth Heading For A Sharp Decline: Crisil

    Pharma Exports Growth Heading For A Sharp Decline: Crisil

    The pharmaceutical sector is heading for a tough time as exports growth in formulations (in US dollar terms) is expected to almost halve to 10-12 per cent annually over the next five years, a report said.

  • No Plea From Pharma Sector To Resolve Issues With FDA: Government

    No Plea From Pharma Sector To Resolve Issues With FDA: Government

    Domestic pharmaceutical industry has not approached the government for early intervention to resolve regulatory issues faced by them in the US, Parliament was informed on Wednesday.

  • Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns

    Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns

    U.S. pharmaceutical companies dominated an annual global ranking of top 10 large-cap stocks with the best five-year returns, according to an analysis released on Tuesday by Boston Consulting Group.

  • Notices Issued To 263 Pharma Firms For Overcharging In FY16

    Notices Issued To 263 Pharma Firms For Overcharging In FY16

    The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 263 firms that were found overcharging during 2015-16, Parliament was informed on Tuesday.

  • Government To Keep Regulating Seed Prices, Says Agriculture Minister

    Government To Keep Regulating Seed Prices, Says  Agriculture Minister

    India will not allow seed companies such as Monsanto to exploit farmers and will keep regulating seed prices, Agriculture Minister Radha Mohan Singh told reporters on Monday.

  • Drug Ban: Delhi High Court To Hear Plea Of Pharma Companies

    Drug Ban: Delhi High Court To Hear Plea Of Pharma Companies

    In what could be the Maggi moment for the pharma majors, the Delhi High Court will today hear cases filed by various pharmaceutical companies against a ban imposed by the central government on 344 drug combinations.

  • GlaxoSmithKline CEO Witty to Retire in March 2017

    GlaxoSmithKline CEO Witty to Retire in March 2017

    GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.

  • Pharma Firms to See Muted Exports, Stable Revenues in FY17: India Ratings

    Pharma Firms to See Muted Exports, Stable Revenues in FY17: India Ratings

    India's pharmaceutical industry is expected to register muted export revenue growth and stable domestic revenue increase in 2016-17, according to a report by India Ratings.

  • Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report

    Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report

    Indian pharmaceutical company Strides Shasun limited has launched a share sale to raise funds up to Rs1,500 crore, IFR reported on Friday, citing a source close to the transaction.

  • Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court

    Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court

    The Delhi High Court on Tuesday told the government not to take any coercive action against pharmaceutical companies including Novartis India Limited and Cipla Ltd in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.

  • Penalise Healthcare Sector Heavily for Unfair Practices: Former Pfizer MD

    Penalise Healthcare Sector Heavily for Unfair Practices: Former Pfizer MD

    Fair trade regulator Competition Commission of India, concerned over a possible nexus between doctors and pharmaceutical companies, has said it will soon carry out a detailed study of pharmaceutical and healthcare services sector in the national capital region (NCR).

  • CCI to Study Pharma Sector Amid Concern Over Unfair Ways

    CCI to Study Pharma Sector Amid Concern Over Unfair Ways

    Concerned over possible a nexus between doctors and pharmaceutical companies, the Competition Commission of India (CCI) will soon carry out a detailed study of pharmaceutical and healthcare services sector in the national capital region (NCR).

  • Top 6 Sensex Companies Add Rs 26,346 Crore in Market Capitalisation

    Top 6 Sensex Companies Add Rs 26,346 Crore in Market Capitalisation

    While RIL, HDFC, SBI, Infosys, HDFC Bank and ONGC saw gain in their market capitalization; TCS, ITC, Coal India and Sun Pharmaceutical -- together witnessed a plunge of Rs 14,766 crore in their valuation.

  • Dr Reddy's, Lupin Clock Double Digit Growth As Stocks Tumble

    Dr Reddy's, Lupin Clock Double Digit Growth As Stocks Tumble

    The double-digit stock market gains of pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year.

  • Government Caps Price of 18 Formulation Packs

    Government Caps Price of 18 Formulation Packs

    The government has brought 18 more drugs, used to treat cancer, inflammation and infections, among others, under price control as part of its efforts to make life saving medicines affordable in the country.

  • TCS, HDFC Bank, 5 Others Lose Rs 60,600 Cr Market Value

    TCS, HDFC Bank, 5 Others Lose Rs 60,600 Cr Market Value

    Seven of the top ten most valued Indian companies saw a combined erosion of Rs 60,600 crore in market valuation in the week to July 24 on account of correction, with Sun Pharmaceutical Industries taking the hardest hit.

  • Biocon Says May Demerge Syngene in Long Run, Post IPO

    Biocon Says May Demerge Syngene in Long Run, Post IPO

    Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.

................................ Advertisement ................................

................................ Advertisement ................................